Zoomedia Events
default image goes here
Windhover’s Pharma Business Strategies for Biomarkers
12/11/2008 - 12/12/2008
San Francisco,CA
Biomarkers are hot – central to the new pharma business strategies. With attrition rates higher and trials ever more expensive, drug companies are insisting on development biomarkers. And Big Pharma’s sharpening focus on high-value specialty products means drugs targeted with biomarkers to particular patient groups are increasingly attractive.
Learn More
About Zoomedia
